Product News: Vision Systems

Imaging System supports intravascular ultrasound, FFR products.

Share Like Tweet Add Email

Press Release Summary:

July 25, 2014 - Designed for usability and processing capabilities, modular POLARIS™ supports Boston Scientific intravascular ultrasound (IVUS) catheters, including coronary, peripheral, and intra-cardiac echo products, as well as fractional flow reserve (FFR) wire. UI and workflow provide necessary information to guide clinical decisions, and system carries CE Mark as well as FDA 510(k) clearance.

Boston Scientific Corp.

One Boston Scientific Place, Natick, MA, 01760, USA

Original Press Release

Boston Scientific Launches POLARIS(TM) Imaging System

Press release date: July 22, 2014

Easy to Use Imaging System to Support Planned Intravascular Ultrasound and Fractional Flow Reserve Products

MARLBOROUGH, Mass. -- Boston Scientific Corporation (NYSE: BSX) has initiated full commercial launch of the new POLARIS(TM) Imaging System.  This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral and intra-cardiac echo products.  The POLARIS System offers enhanced ease-of-use and more powerful processing capabilities.  Its modular design would also support the planned release of new Boston Scientific imaging products including a fractional flow reserve (FFR) wire, a new family of IVUS catheters, enhanced software features and better system control tools.

Working in collaboration with physicians, nurses, technicians and software design experts, Boston Scientific identified a need to improve the experience for customers involved in intravascular imaging procedures.  Common challenges included confusing work flows, increased procedure times, and difficult image interpretation.  Boston Scientific has developed a system that simplifies intravascular guidance.  The POLARIS System is designed to be smart, fast and accurate.  The user interface and workflow have been redesigned and enhanced to provide for greater ease of use, while providing the necessary information to guide clinical decisions.

The POLARIS System has CE Mark and FDA 510(k) clearance.  It has been evaluated in numerous hospitals in the U.S. and Europe, and was showcased during live cases at the EuroPCR conference in May.

"The POLARIS System is an advance for intravascular imaging," said Lowell Satler, M.D., director of Coronary Interventions, MedStar Washington Hospital Center in Washington, D.C.  "The improved ease-of-use and image processing simplifies the procedure and enables our team to quickly obtain the information needed to treat patients."

Boston Scientific will offer customers an opportunity to upgrade their existing iLab System to the state-of-the-art POLARIS System.

"There are overwhelming data demonstrating that using IVUS improves patient outcomes," said Isaac Zacharias, vice president and general manager, Imaging, Boston Scientific.  "The POLARIS System represents the ongoing commitment of Boston Scientific to develop products that improve patient outcomes by providing physicians improved IVUS guidance in their daily practice."

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:
Media: Ryan Davenport
Global Media Relations
Boston Scientific Corporation
763-494-2664 (office)
media@bsci.com

Simonetta Balbi
PR and Corporate Communication EMEA
Boston Scientific Corporation
+ 39 3387936422 (mobile)
+ 39 0106060281 (direct)
Balbis@bsci.com

Susie Lisa, CFA
Investor Relations
Boston Scientific Corporation
508-683-5565 (office)
investor_relations@bsci.com

Share Like Tweet Add Email

LIKE THIS ARTICLE? DON’T MISS OUT ON OTHERS! Get Thomasnet’s industry newsletter now

Comments

comments powered by Disqus